C
Camille Dumont
Researcher at Claude Bernard University Lyon 1
Publications - 7
Citations - 150
Camille Dumont is an academic researcher from Claude Bernard University Lyon 1. The author has contributed to research in topics: Solid lipid nanoparticle & Nanocarriers. The author has an hindex of 4, co-authored 5 publications receiving 97 citations. Previous affiliations of Camille Dumont include University of Lyon.
Papers
More filters
Journal ArticleDOI
Lipid-based nanosuspensions for oral delivery of peptides, a critical review
TL;DR: Different techniques used to produce SLN and NLC with potential or effective peptide encapsulation are outlined and basic principles of covalent and non-covalent lipidization are described and discussed as a prerequisite to improve hydrophilic peptides encapsulation in lipid-based nanosuspensions.
Journal ArticleDOI
Development of self emulsifying lipid formulations of BCS class II drugs with low to medium lipophilicity.
Vincent Jannin,Stéphanie Chevrier,Matthieu Michenaud,Camille Dumont,Silvia Belotti,Yann Chavant,Frédéric Demarne +6 more
TL;DR: The potential of surfactant-based formulations - i.e., Type IV systems from the lipid formulation classification system - for this type of hydrophobic drug is demonstrated.
Journal ArticleDOI
In-vitro evaluation of solid lipid nanoparticles: Ability to encapsulate, release and ensure effective protection of peptides in the gastrointestinal tract
TL;DR: Despite an increased amount of encapsulated peptide in solid lipid-based nanoparticles following HIP formation, the important specific surface area linked to their platelet structures resulted in an important peptide release upon dispersion in FaSSIF-V2 and limited protection towards enzymatic degradation.
Journal ArticleDOI
A proof-of-concept for developing oral lipidized peptide Nanostructured Lipid Carrier formulations
Camille Dumont,Vincent Jannin,Cédric Miolane,Quentin Lelong,Jean-Pierre Valour,Sébastien Urbaniak,Hatem Fessi,Sandrine Bourgeois +7 more
TL;DR: In this paper, the authors developed a protocol to encapsulate lipidized-peptides in Nanostructured Lipid Carrier (NLC) by High Pressure Homogenization (HPH) for oral delivery.
Journal ArticleDOI
Solid lipid nanocarriers diffuse effectively through mucus and enter intestinal cells - but where is my peptide?
Camille Dumont,Ana Beloqui,Cédric Miolane,Sandrine Bourgeois,Véronique Préat,Hatem Fessi,Vincent Jannin +6 more
TL;DR: Improvement of peptide lipidization should maintain encapsulation and enable benefit from nanocarriers enhanced intestinal transport to improve peptide transport across the intestinal border.